Stocks
CME (CME) EBITDA margin US GAAP (year values) |
|||||||||
| 2022 | 2023 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 80.0% | 67.9% | 83.6% | 82.2% | 87.7% | 84.2% | ||
| Changes by years, y/y, % | 0pp | -12pp | +16pp | -1pp | +6pp | +6.4% | |||
CME. EBITDA margin, %
CME. EBITDA margin, changes, pp
CME (CME) EBITDA margin US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| EBITDA margin, % | ? | 83.4% | 86.2% | 84.8% | 96.4% | 71.1% | 84.2% | |
| Changes by years, y/y, % | +0pp | +3pp | +3pp | +16pp | -12pp | |||
| Changes by quarters, q/q, % | +3pp | +3pp | -1pp | +12pp | -25pp | |||
